{"entity":{"type":"insider","cik":"0001440771","url":"/insider/0001440771","json_url":"/insider/0001440771.json","name":"Stonepine Capital Management, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":5,"first":"2016-06-21","last":"2017-05-15","span_basis":"filed_date"},"name_variants":[{"name":"Stonepine Capital Management, LLC","source":"filing","n_filings":5,"first_seen":"2016-06-21","last_seen":"2017-05-15"}],"transactions":[{"id":5074218,"accession":"0001140361-17-020813","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-020813","line_url":"/filing/0001140361-17-020813#line-2","is_derivative":false,"issuer_cik":"0001440771","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001440771","owner_cik":"0001440771","owner_name":"Stonepine Capital Management, LLC","owner_url":"/insider/0001440771","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":436070.0,"shares_display":"436,070","price_per_share":7.4004,"price_display":"7.40","price_state":"stated","total_value":3227092.428,"total_display":"3,227,092.43","shares_owned_after":1976310.0,"shares_owned_after_display":"1,976,310","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-12","filed_date":"2017-05-15","scope":"insider"},{"id":5074214,"accession":"0001140361-17-020813","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-020813","line_url":"/filing/0001140361-17-020813#line-1","is_derivative":false,"issuer_cik":"0001440771","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001440771","owner_cik":"0001440771","owner_name":"Stonepine Capital Management, LLC","owner_url":"/insider/0001440771","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73930.0,"shares_display":"73,930","price_per_share":7.4004,"price_display":"7.40","price_state":"stated","total_value":547111.572,"total_display":"547,111.57","shares_owned_after":1902380.0,"shares_owned_after_display":"1,902,380","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-12","filed_date":"2017-05-15","scope":"insider"},{"id":4752237,"accession":"0001140361-17-019827","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-17-019827","line_url":"/filing/0001140361-17-019827#line-6","is_derivative":false,"issuer_cik":"0001440771","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001440771","owner_cik":"0001440771","owner_name":"Stonepine Capital Management, LLC","owner_url":"/insider/0001440771","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7696.0,"shares_display":"7,696","price_per_share":7.9647,"price_display":"7.96","price_state":"stated","total_value":61296.3312,"total_display":"61,296.33","shares_owned_after":2413684.0,"shares_owned_after_display":"2,413,684","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-11","filed_date":"2017-05-11","scope":"insider"},{"id":4752233,"accession":"0001140361-17-019827","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-17-019827","line_url":"/filing/0001140361-17-019827#line-5","is_derivative":false,"issuer_cik":"0001440771","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001440771","owner_cik":"0001440771","owner_name":"Stonepine Capital Management, LLC","owner_url":"/insider/0001440771","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1304.0,"shares_display":"1,304","price_per_share":7.9647,"price_display":"7.96","price_state":"stated","total_value":10385.9688,"total_display":"10,385.97","shares_owned_after":2412380.0,"shares_owned_after_display":"2,412,380","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-11","filed_date":"2017-05-11","scope":"insider"},{"id":4752229,"accession":"0001140361-17-019827","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-019827","line_url":"/filing/0001140361-17-019827#line-4","is_derivative":false,"issuer_cik":"0001440771","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001440771","owner_cik":"0001440771","owner_name":"Stonepine Capital Management, LLC","owner_url":"/insider/0001440771","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6412.0,"shares_display":"6,412","price_per_share":7.7727,"price_display":"7.77","price_state":"stated","total_value":49838.5524,"total_display":"49,838.55","shares_owned_after":2422468.0,"shares_owned_after_display":"2,422,468","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-10","filed_date":"2017-05-11","scope":"insider"},{"id":4752222,"accession":"0001140361-17-019827","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-019827","line_url":"/filing/0001140361-17-019827#line-3","is_derivative":false,"issuer_cik":"0001440771","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001440771","owner_cik":"0001440771","owner_name":"Stonepine Capital Management, LLC","owner_url":"/insider/0001440771","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1088.0,"shares_display":"1,088","price_per_share":7.7727,"price_display":"7.77","price_state":"stated","total_value":8456.6976,"total_display":"8,456.70","shares_owned_after":2421380.0,"shares_owned_after_display":"2,421,380","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-10","filed_date":"2017-05-11","scope":"insider"},{"id":4752218,"accession":"0001140361-17-019827","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-019827","line_url":"/filing/0001140361-17-019827#line-2","is_derivative":false,"issuer_cik":"0001440771","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001440771","owner_cik":"0001440771","owner_name":"Stonepine Capital Management, LLC","owner_url":"/insider/0001440771","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":195059.0,"shares_display":"195,059","price_per_share":7.6351,"price_display":"7.64","price_state":"stated","total_value":1489294.9709,"total_display":"1,489,294.97","shares_owned_after":2461950.0,"shares_owned_after_display":"2,461,950","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-09","filed_date":"2017-05-11","scope":"insider"},{"id":4752208,"accession":"0001140361-17-019827","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-019827","line_url":"/filing/0001140361-17-019827#line-1","is_derivative":false,"issuer_cik":"0001440771","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001440771","owner_cik":"0001440771","owner_name":"Stonepine Capital Management, LLC","owner_url":"/insider/0001440771","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33070.0,"shares_display":"33,070","price_per_share":7.6351,"price_display":"7.64","price_state":"stated","total_value":252492.757,"total_display":"252,492.76","shares_owned_after":2428880.0,"shares_owned_after_display":"2,428,880","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-09","filed_date":"2017-05-11","scope":"insider"},{"id":4089331,"accession":"0001140361-17-018662","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-018662","line_url":"/filing/0001140361-17-018662#line-4","is_derivative":false,"issuer_cik":"0001440771","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001440771","owner_cik":"0001440771","owner_name":"Stonepine Capital Management, LLC","owner_url":"/insider/0001440771","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":172000.0,"shares_display":"172,000","price_per_share":7.691,"price_display":"7.69","price_state":"stated","total_value":1322852.0,"total_display":"1,322,852.00","shares_owned_after":2686169.0,"shares_owned_after_display":"2,686,169","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-04","filed_date":"2017-05-05","scope":"insider"},{"id":4089329,"accession":"0001140361-17-018662","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-018662","line_url":"/filing/0001140361-17-018662#line-3","is_derivative":false,"issuer_cik":"0001440771","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001440771","owner_cik":"0001440771","owner_name":"Stonepine Capital Management, LLC","owner_url":"/insider/0001440771","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29160.0,"shares_display":"29,160","price_per_share":7.691,"price_display":"7.69","price_state":"stated","total_value":224269.56,"total_display":"224,269.56","shares_owned_after":2657009.0,"shares_owned_after_display":"2,657,009","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-04","filed_date":"2017-05-05","scope":"insider"},{"id":4089326,"accession":"0001140361-17-018662","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-018662","line_url":"/filing/0001140361-17-018662#line-2","is_derivative":false,"issuer_cik":"0001440771","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001440771","owner_cik":"0001440771","owner_name":"Stonepine Capital Management, LLC","owner_url":"/insider/0001440771","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13808.0,"shares_display":"13,808","price_per_share":7.7929,"price_display":"7.79","price_state":"stated","total_value":107604.3632,"total_display":"107,604.36","shares_owned_after":2860509.0,"shares_owned_after_display":"2,860,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-03","filed_date":"2017-05-05","scope":"insider"},{"id":4089324,"accession":"0001140361-17-018662","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-018662","line_url":"/filing/0001140361-17-018662#line-1","is_derivative":false,"issuer_cik":"0001440771","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001440771","owner_cik":"0001440771","owner_name":"Stonepine Capital Management, LLC","owner_url":"/insider/0001440771","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2340.0,"shares_display":"2,340","price_per_share":7.7929,"price_display":"7.79","price_state":"stated","total_value":18235.386,"total_display":"18,235.39","shares_owned_after":2858169.0,"shares_owned_after_display":"2,858,169","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-03","filed_date":"2017-05-05","scope":"insider"},{"id":4751790,"accession":"0001140361-17-012865","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-012865","line_url":"/filing/0001140361-17-012865#line-1","is_derivative":false,"issuer_cik":"0000879682","issuer_name":"VIVEVE MEDICAL, INC.","issuer_ticker":"VIVE","issuer_name_source":null,"issuer_url":"/issuer/0000879682","owner_cik":null,"owner_name":"STONEPINE CAPITAL, L.P.; Stonepine Capital Management, LLC; Plexico Jon M; LYNCH TIMOTHY P","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250000.0,"shares_display":"1,250,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","shares_owned_after":3849711.0,"shares_owned_after_display":"3,849,711","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-17","filed_date":"2017-03-21","scope":"insider"},{"id":3147382,"accession":"0001437749-16-034195","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-16-034195","line_url":"/filing/0001437749-16-034195#line-1","is_derivative":false,"issuer_cik":"0000879682","issuer_name":"VIVEVE MEDICAL, INC.","issuer_ticker":"VIVE","issuer_name_source":null,"issuer_url":"/issuer/0000879682","owner_cik":null,"owner_name":"Stonepine Capital Management, LLC; LYNCH TIMOTHY P; STONEPINE CAPITAL, L.P.; Plexico Jon M","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","shares_owned_after":2599711.0,"shares_owned_after_display":"2,599,711","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-17","filed_date":"2016-06-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001588972","name":"Recro Pharma, Inc.","url":"/issuer/0001588972","role":"Ten percent owner","n_filings":3,"first_seen":"2017-05-05","last_seen":"2017-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000879682","name":"VIVEVE MEDICAL, INC.","url":"/issuer/0000879682","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2016-06-21","last_seen":"2017-03-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001440771","retrieved_at":"2026-08-21T22:33:22+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}